Today: 13 May 2026
Browse Category

OTC:ATPC 11 December 2025

Biggest Stock Gainers Today in the U.S. Market (December 11, 2025): Takeovers, AI Winners and Micro‑Cap Rockets

Biggest Stock Gainers Today in the U.S. Market (December 11, 2025): Takeovers, AI Winners and Micro‑Cap Rockets

The Dow Jones Industrial Average hit an intraday record Thursday, rising 1.2%, while the S&P 500 slipped 0.2% and the Nasdaq 100 fell just over 1% after Oracle’s post-earnings drop. Small caps surged, with the Russell 2000 up nearly 1%. Individual gainers included micro-cap biotechs, digital asset firms, and a pet-pharmacy takeover target.
11 December 2025
··
Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

Biggest Stock Losers Today: Oracle’s AI Shock and Micro‑Cap Meltdowns Rock the U.S. Market (Dec. 11, 2025)

Oracle shares plunged over 12% Thursday after the company missed revenue estimates and warned of higher AI-related spending, fueling concerns about an “AI bubble.” U.S. stock futures fell, with S&P 500 and Nasdaq 100 contracts down as much as 1.2%. The selloff followed the Federal Reserve’s third straight rate cut, which failed to lift markets. Several micro-cap stocks also posted sharp losses.
11 December 2025
·······

Stock Market Today

  • Pelagos Insurance Q1 CY2026 Earnings Beat Expectations Despite Revenue Decline
    May 13, 2026, 5:29 PM EDT. Pelagos Insurance (NYSE:PLGO) reported Q1 CY2026 earnings surpassing analysts' estimates with a GAAP EPS of $1.15, 19.1% above the consensus of $0.97. Revenue was $610.6 million, down 7.3% year on year but still 4.7% ahead of forecasts. Net premiums earned fell 5.7% to $568.5 million yet beat estimates by 8.1%. The combined ratio, a measure of underwriting profitability, improved to 86.6%, beating analyst expectations by 90 basis points. Book value per share rose 21% year over year to $26.22. CEO Dan Burrows highlighted strong premium growth and a healthy 15.2% operating return on average equity. Pelagos continues to leverage its specialty insurance model and underwriting partnerships to drive profitable growth amid evolving market conditions.

Latest articles

Mobileye Stock Jumps 14% as Robotaxi Plans Pull Investors Back In

Mobileye Stock Jumps 14% as Robotaxi Plans Pull Investors Back In

13 May 2026
Mobileye shares surged 14.1% to $10.53 on Nasdaq Wednesday after the company reported a 27% jump in first-quarter revenue and raised its 2026 outlook. The company authorized a $250 million share buyback. After-hours trading was flat. Mobileye cited strong EyeQ chip demand but warned of risks from China market uncertainty and a recent goodwill write-down.
Fermi Stock Faces A High-Stakes Q1 Test As Founder Fight Deepens

Fermi Stock Faces A High-Stakes Q1 Test As Founder Fight Deepens

13 May 2026
Toby Neugebauer and allied shareholders filed new proxy materials to press for board changes at Fermi Inc., despite the board’s claim that the May 29 special meeting has been canceled. The group plans to use separate proxy cards for the disputed May 29 vote and a shareholder-called meeting expected around June 30. Fermi’s board opposes Neugebauer’s push for control and a quick sale. First-quarter results are due Thursday.
Fervo Energy Stock Jumps 35% in Nasdaq Debut as AI Power Demand Pulls Geothermal Into Wall Street’s Spotlight

Fervo Energy Stock Jumps 35% in Nasdaq Debut as AI Power Demand Pulls Geothermal Into Wall Street’s Spotlight

13 May 2026
Fervo Energy shares closed at $36.54, 35% above the $27 IPO price, in their Nasdaq debut Wednesday, valuing the company at $10.36 billion. The Houston geothermal developer raised $1.89 billion by selling 70 million shares. Fervo reported 2025 revenue of $138,000 and a net loss of $57.8 million. The company holds $7.2 billion in potential contracted revenue but has yet to deliver commercial power.
Wix Stock Plunges 27% After Q1 Earnings Miss as AI Spending Spooks Investors

Wix Stock Plunges 27% After Q1 Earnings Miss as AI Spending Spooks Investors

13 May 2026
Wix shares fell 27.1% to $55.32 after first-quarter adjusted earnings missed estimates and the company posted a GAAP net loss of $57.5 million. Revenue rose 14% to $541.2 million, but non-GAAP operating margin dropped to 5% from 21% a year earlier. JPMorgan cut its price target to $86, citing ongoing heavy investment. Research and development costs jumped to $178.2 million from $127.5 million.
Go toTop